10Nov 2023
Respiratory Motion-Managed Radiotherapy Shows Promise for Non-Small Cell Lung Cancer

Respiratory Motion-Managed Radiotherapy Shows Promise for Non-Small Cell Lung Cancer

A study found that respiratory motion-managed radiotherapy (RT) can reduce side effects and improve outcomes in non-small cell lung cancer (NSCLC) patients. The study involved 31 patients treated with RT using the 4D-CT-based volumetric arc therapy technique. They found that PTV did not increase, the target was covered with 95% accuracy, and all risky organ doses were significantly lower. Two-year survival of 26% was achieved without serious side effects.

  • #oncology

Like

Save

Share